Release Date: 19/09/19 09:58 Summary: BNO - FDA Fast Track Application Price Sensitive: Yes Download Document 84.66KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%